Calluna Pharma

Biotech · Oslo, NO

Antibody therapies for inflammatory and fibrotic diseases

Funding history

Date	Round	Amount
Jan 2024	Series A Norwegian biotech Calluna Pharma, formed by merging Oxitope Pharma and Arxx Therapeutics, raised a EUR 75M Series A led by Forbion.	$81M

ForbionInvestinorSarsia